홈 카테고리 맞춤형시장조사 국제컨퍼런스 글로벌 파트너 메일링 서비스 회사소개회사소개 Contact Us
English Japaness Chinese
Home > 시장보고서 > 메디컬디바이스 > 심혈관장치 > Global Competitor Insights for Peripheral Vascular Disease 2008
카테고리
메디컬디바이스 (4663)
내시경 (161)
분자영상/조영제 (28)
심혈관장치 (336)
안과기기 (102)
의료용 영상진단장치 (416)
의료용 일회용품 (77)
정형외과 (340)
창상관리 (163)
체외진단장치(IVD) (520)
초음파 (55)
치과기기 (176)
카테터 (239)
핵의료 (76)
헬스케어 IT (315)
환자모니터링 (390)
CT/MRI/X-ray (173)
시장보고서

Global Competitor Insights for Peripheral Vascular Disease 2008

리서치사 Millennium Research Group
발행일 2008년 06월 상품코드 73368
페이지 정보
가격
US $ 4,197 ￦ 5,000,700 Web Access and PDF Download (Single user license)
US $ 6,300 ￦ 7,506,400 Web Access and PDF Download (Corporate use license)


영문목차

Abstract

MRG' s Global Competitor Insights for Peripheral Vascular Devices 2008 report covers the US, Europe (France, Germany, Italy, and the UK), and Japan, and includes PV stents, percutaneous transluminal angioplasty (PTA) balloon catheters, embolic protection devices (EPDs), inferior vena cava filters (IVCFs), aortic stent grafts, and PV accessory devices.

Millennium Research Group' s (MRG) Global Competitor Insights for Peripheral Vascular Devices 2008 report provides an in depth analysis of each of the top nine competitors in the global peripheral vascular (PV) device market. This report serves as a tool for evaluating each company' s performance relative to its competitors.

Table of Contents

EXECUTIVE SUMMARY

METHODOLOGY

1.0 GLOBAL PERIPHERAL VASCULAR DEVICE MARKET

  • 1.1 Market Overview
    • 1.1.1 Procedures
    • 1.1.2 Peripheral Vascular Devices
    • 1.1.2.1 Peripheral Vascular Stents
    • 1.1.2.2 Percutaneous Transluminal Angioplasty Balloon Catheters
    • 1.1.2.3 Embolic Protection Devices
    • 1.1.2.4 Inferior Vena Cava Filters
    • 1.1.2.5 Aortic Stent Grafts
    • 1.1.2.6 Peripheral Vascular Accessory Devices
  • 1.2 Regional Analysis
    • 1.2.1 Global Analysis
    • 1.2.2 US Analysis
    • 1.2.3 Europe Analysis
    • 1.2.4 Japan Analysis

2.0 CORDIS (JOHNSON & JOHNSON)

  • 2.1 Company Overview
    • 2.1.1 Recent Events
    • 2.1.2 Company Analysis
    • 2.1.3 S.W.O.T. Analysis
    • 2.1.3.1 Strengths
    • 2.1.3.2 Weaknesses
    • 2.1.3.3 Opportunities
    • 2.1.3.4 Threats
  • 2.2 Peripheral Vascular Device Profile
    • 2.2.1 Peripheral Vascular Stent Summary
    • 2.2.2 PTA Balloon Catheter Summary
    • 2.2.3 Embolic Protection Device Summary
    • 2.2.4 Inferior Vena Cava Filter Summary
    • 2.2.5 Peripheral Vascular Accessory Device Summary

3.0 BOSTON SCIENTIFIC

  • 3.1 Company Overview
    • 3.1.1 Recent Events
    • 3.1.2 Company Analysis
    • 3.1.3 S.W.O.T. Analysis
    • 3.1.3.1 Strengths
    • 3.1.3.2 Weaknesses
    • 3.1.3.3 Opportunities
    • 3.1.3.4 Threats
  • 3.2 Peripheral Vascular Device Profile
    • 3.2.1 Peripheral Vascular Stent Summary
    • 3.2.2 PTA Balloon Catheter Summary
    • 3.2.3 Embolic Protection Device Summary
    • 3.2.4 Inferior Vena Cava Filter Summary
    • 3.2.5 Peripheral Vascular Accessory Device Summary

4.0 W.L. GORE

  • 4.1 Company Overview
    • 4.1.1 Recent Events
    • 4.1.2 Company Analysis
    • 4.1.3 S.W.O.T. Analysis
    • 4.1.3.1 Strengths
    • 4.1.3.2 Weaknesses
    • 4.1.3.3 Opportunities
    • 4.1.3.4 Threats
  • 4.2 Peripheral Vascular Device Profile
    • 4.2.1 Peripheral Vascular Stent Device Summary
    • 4.2.2 Embolic Protection Device Summary
    • 4.2.3 Aortic Stent Graft Summary

5.0 COOK MEDICAL

  • 5.1 Company Overview
    • 5.1.1 Recent Events
    • 5.1.2 Company Analysis
    • 5.1.3 S.W.O.T. Analysis
    • 5.1.3.1 Strengths
    • 5.1.3.2 Weaknesses
    • 5.1.3.3 Opportunities
    • 5.1.3.4 Threats
  • 5.2 Peripheral Vascular Device Profile
    • 5.2.1 Peripheral Vascular Stent Summary
    • 5.2.2 PTA Balloon Catheter Summary
    • 5.2.3 Inferior Vena Cava Filter Summary
    • 5.2.4 Aortic Stent Graft Summary
    • 5.2.5 Peripheral Vascular Accessory Device Summary

6.0 ABBOTT VASCULAR

  • 6.1 Company Overview
    • 6.1.1 Recent Events
    • 6.1.2 Company Analysis
    • 6.1.3 S.W.O.T. Analysis
    • 6.1.3.1 Strengths
    • 6.1.3.2 Weaknesses
    • 6.1.3.3 Opportunities
    • 6.1.3.4 Threats
  • 6.2 Peripheral Vascular Device Profile
    • 6.2.1 Peripheral Vascular Stent Device Summary
    • 6.2.2 PTA Balloon Catheter Summary
    • 6.2.3 Embolic Protection Device Summary
    • 6.2.4 Peripheral Vascular Accessory Device Summary

7.0 C. R. BARD

  • 7.1 Company Overview
    • 7.1.1 Recent Events
    • 7.1.2 Company Analysis
    • 7.1.3 S.W.O.T. Analysis
    • 7.1.3.1 Strengths
    • 7.1.3.2 Weaknesses
    • 7.1.3.3 Opportunities
    • 7.1.3.4 Threats
    • 7.2 Peripheral Vascular Device Profile
    • 7.2.1 Peripheral Vascular Stent Summary
    • 7.2.2 PTA Balloon Catheter Summary
    • 7.2.3 Inferior Vena Cava Filter Summary

8.0 MEDTRONIC

  • 8.1 Company Overview
    • 8.1.1 Recent Events
    • 8.1.2 Company Analysis
    • 8.1.3 S.W.O.T. Analysis
    • 8.1.3.1 Strengths
    • 8.1.3.2 Weaknesses
    • 8.1.3.3 Opportunities
    • 8.1.3.4 Threats
  • 8.2 Peripheral Vascular Device Profile
    • 8.2.1 Peripheral Vascular Stent Summary
    • 8.2.2 Embolic Protection Device Summary
    • 8.2.3 Aortic Stent Graft Summary

9.0 TERUMO MEDICAL

  • 9.1 Company Overview
    • 9.1.1 Recent Events
    • 9.1.2 Company Analysis
    • 9.1.3 S.W.O.T. Analysis
    • 9.1.3.1 Strengths
    • 9.1.3.2 Weaknesses
    • 9.1.3.3 Opportunities
    • 9.1.3.4 Threats
  • 9.2 Peripheral Vascular Device Profile
    • 9.2.1 Aortic Stent Graft Device Summary
    • 9.2.2 Peripheral Vascular Accessory Device Summary

10.0 EV3

  • 10.1 Company Overview
    • 10.1.1 Recent Events
    • 10.1.2 Company Analysis
    • 10.1.3 S.W.O.T. Analysis
    • 10.1.3.1 Strengths
    • 10.1.3.2 Weaknesses
    • 10.1.3.3 Opportunities
    • 10.1.3.4 Threats
  • 10.2 Peripheral Vascular Device Profile
    • 10.2.1 Peripheral Vascular Stent Summary
    • 10.2.2 PTA Balloon Catheter Summary
    • 10.2.3 Embolic Protection Device Summary
    • 10.2.4 Peripheral Vascular Accessory Device Summary

APPENDIX A: MRG ACRONYMS AND INITIALISMS

Back to Top